Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Dicerna Licenses City of Hope RNAI IP and Pulls Down $13 million Series A

Nov 01 2007

• By Chris Morrison

Related Content

Merck Nabs Pole Position in RNAi With $1.1 Billion Sirna Buy

Nov 01 2006

Alnylam Takes Platform Monetization to a Whole New and Non-Exclusive Level

Jul 01 2007

Early Movers in RNAi

Oct 01 2007

In RNAi, Technology Proliferates Beyond the Big Two

Apr 01 2007

Related Companies

Dicerna Pharmaceuticals, Inc.

City of Hope

City of Hope

Integrated DNA Technologies

Alnylam Pharmaceuticals Inc.

Merck & Co., Inc.

Adhera Therapeutics, Inc.

Novartis AG

Additional Topics

Business Strategies BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window